-
OncoLifeS Follow-up 6 - 12- 18- 24 months
We have established a hospital-based data-biobank, entitled OncoLifeS (Oncological Life Study: Living well as a cancer survivor) to link routinely collected clinical data with... -
OncoLifeS Baseline
Collection at inclusion -
OncoLifeS Follow-up 3 months
Questionnaire -
OncoLifeS Head&Neck cancer
Include cancers in the larynx, throat, lips, mouth, nose and salivary glands. -
OncoLifeS Lung oncology
Type of cancer starts in the lungs. -
OncoLifeS Hereditary Breast and Ovarian Cancer
Patients with A “mutation,” or harmful genetic change, in either BRCA1 or BRCA2 gives a woman an increased lifetime risk of developing breast and ovarian cancers. -
OncoLifeS Skin cancer
Patients with squamous cell carcinoma -
OncoLifeS Colorectal cancer
Patients with small intestine, colon, rectum and anal cancer and patients with a hereditary predisposition to colorectal cancer. -
OncoLifeS Hematological oncology
Oncology patients with a hematologic tumor, such as lymph node cancer, plasma cell tumors, leukemia, myelodysplastic syndromes (MDS), myeloproliferative disorders (MPN), diffuse... -
OncoLifeS Bone and soft-tissue oncology
Bone and Soft Tissue Tumors, such as sarcomas and Gastro Intestinale Stroma Tumor (GIST). -
OncoLifeS Adrenal cancer
The type of cancer in the cortex of the adrenal gland. -
OncoLifeS Anaplastic thyroid carcinoma
Patients with an Anaplastic thyroid carcinoma (ATC). -
OncoLifeS Adolescents and young adults (AYA)
Adolescents and young adults (AYAs) diagnosed with cancer between the ages of 18 and 39. -
OncoLifeS Gynecological oncology
Tumors of the female reproductive system, such as ovarian cancer, vaginal cancer, cervical cancer, vulva cancer. -
OncoLifeS Testicular oncology
Patients with germ cell tumors (seminoma and non-seminoma)) of the testis -
OncoLifeS Neuro-endocrine oncology
Oncology patients with a neuroendocrine (NET) tumor. -
OncoLifeS Esophageal and Stomach Carcinoma
Patients with oesophageal, gastric cancer and Barrett's esophagus. -
OncoLifeS Hepato Pancreato Biliary Tumors
Patients with tumors in the liver, pancreas, gallbladder and bile ducts. -
OncoLifeS Medical oncology/immunotherapy
Oncology patients treated with immunotherapy. -
OncoLifeS Hereditary Breast and Ovarian Cancer (historical)
Patients with A “mutation,” or harmful genetic change, in either BRCA1 or BRCA2 gives a woman an increased lifetime risk of developing breast and ovarian cancers.